• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

补体膜攻击复合物:通过五种亲水性血浆蛋白融合产生高亲和力磷脂结合位点。

Membrane attack complex of complement: generation of high-affinity phospholipid binding sites by fusion of five hydrophilic plasma proteins.

作者信息

Podack E R, Biesecker G, Müller-Eberhard H J

出版信息

Proc Natl Acad Sci U S A. 1979 Feb;76(2):897-901. doi: 10.1073/pnas.76.2.897.

DOI:10.1073/pnas.76.2.897
PMID:284414
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC383086/
Abstract

The molecular basis of the membranolytic activity of the membrane attack complex (MAC) of complement was investigated. By using density gradient equilibrium ultracentrifugation, the binding of egg yolk lecithin to the isolated MAC and to its intermediate complexes and precursor proteins was measured. No stable phospholipid--protein complexes were formed with the MAC precursor components C5b--6, C7, C8, and C9. Stable complexes of phospholipid and protein were formed by C5b--7, C5b--8, C5b--9, and the MAC (C5b--9 dimer) and they exhibited densities of 1.2164, 1.184, 1.2055, and 1.2275 g/ml, respectively. The molar phospholipid/protein ratios for the four complexes were determined to be: C5b--7, 399:1, C5b--5, 841:1; C5b--9, 918:1; and C5b--9 dimer, 1460:1. Electron microscopy of the isolated phospholipid--protein complexes revealed no lipid bilayer structures. The magnitude of the phospholipid binding capacity of the MAC is consistent with the interpretation that the MAC forms phospholipid--protein mixed in micelles in lipid bilayers and biological membranes and thus causes formation of hydrophilic lipid channels.

摘要

对补体膜攻击复合物(MAC)的膜溶解活性的分子基础进行了研究。通过使用密度梯度平衡超速离心法,测定了蛋黄卵磷脂与分离出的MAC及其中间复合物和前体蛋白的结合情况。MAC前体成分C5b-6、C7、C8和C9未形成稳定的磷脂-蛋白质复合物。磷脂和蛋白质的稳定复合物由C5b-7、C5b-8、C5b-9和MAC(C5b-9二聚体)形成,它们的密度分别为1.2164、1.184、1.2055和1.2275 g/ml。四种复合物的摩尔磷脂/蛋白质比率分别确定为:C5b-7为399:1,C5b-8为841:1;C5b-9为918:1;C5b-9二聚体为1460:1。对分离出的磷脂-蛋白质复合物的电子显微镜观察未发现脂质双层结构。MAC的磷脂结合能力大小与以下解释一致,即MAC在脂质双层和生物膜中形成磷脂-蛋白质混合胶束,从而导致亲水性脂质通道的形成。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87f3/383086/703e526b213b/pnas00002-0358-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87f3/383086/a3f172a94546/pnas00002-0356-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87f3/383086/703e526b213b/pnas00002-0358-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87f3/383086/a3f172a94546/pnas00002-0356-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87f3/383086/703e526b213b/pnas00002-0358-a.jpg

相似文献

1
Membrane attack complex of complement: generation of high-affinity phospholipid binding sites by fusion of five hydrophilic plasma proteins.补体膜攻击复合物:通过五种亲水性血浆蛋白融合产生高亲和力磷脂结合位点。
Proc Natl Acad Sci U S A. 1979 Feb;76(2):897-901. doi: 10.1073/pnas.76.2.897.
2
Evidence for a two-domain structure of the terminal membrane C5b-9 complex of human complement.人类补体末端膜C5b-9复合物两结构域结构的证据。
Proc Natl Acad Sci U S A. 1979 Nov;76(11):5872-6. doi: 10.1073/pnas.76.11.5872.
3
Membrane attack complex of complement: a structural analysis of its assembly.补体膜攻击复合物:其组装的结构分析
J Exp Med. 1980 Feb 1;151(2):301-13. doi: 10.1084/jem.151.2.301.
4
Membrane attack by complement.补体介导的膜攻击。
Mol Immunol. 1984 Jul;21(7):589-603. doi: 10.1016/0161-5890(84)90044-0.
5
Transmembrane channel-formation by five complement proteins.五种补体蛋白形成跨膜通道。
Biochem Soc Symp. 1985;50:235-46.
6
Fluid-phase assembly of the membrane attack complex of complement.补体膜攻击复合物的液相组装。
Biochemistry. 1986 Feb 25;25(4):841-51. doi: 10.1021/bi00352a016.
7
Molecular organization of C9 within the membrane attack complex of complement. Induction of circular C9 polymerization by the C5b-8 assembly.补体膜攻击复合物中C9的分子组织。C5b-8组装诱导C9环状聚合。
J Exp Med. 1982 Jul 1;156(1):268-82. doi: 10.1084/jem.156.1.268.
8
Membrane attack complex of complement: distribution of subunits between the hydrocarbon phase of target membranes and water.补体膜攻击复合物:靶膜碳氢相和水之间亚基的分布
Proc Natl Acad Sci U S A. 1981 Jul;78(7):4544-8. doi: 10.1073/pnas.78.7.4544.
9
The membrane attack mechanism of complement: photolabeling reveals insertion of terminal proteins into target membrane.补体的膜攻击机制:光标记揭示末端蛋白插入靶膜。
J Immunol. 1981 Jul;127(1):380-6.
10
Complement lysis: the ultrastructure and orientation of the C5b-9 complex on target sheep erythrocyte membranes.补体溶解:C5b-9复合物在靶绵羊红细胞膜上的超微结构与取向
Scand J Immunol. 1978;7(1):45-6. doi: 10.1111/j.1365-3083.1978.tb00425.x.

引用本文的文献

1
Complement-targeted therapies in kidney transplantation-insights from preclinical studies.补体靶向治疗在肾移植中的研究进展。
Front Immunol. 2022 Oct 13;13:984090. doi: 10.3389/fimmu.2022.984090. eCollection 2022.
2
Interactions Between Pathogenic and the Complement System: A Review of Potential Immune Evasion Mechanisms.病原体与补体系统的相互作用:潜在免疫逃避机制的综述。
Front Cell Infect Microbiol. 2021 Sep 30;11:701362. doi: 10.3389/fcimb.2021.701362. eCollection 2021.
3
The mystery behind membrane insertion: a review of the complement membrane attack complex.

本文引用的文献

1
LESIONS IN ERYTHROCYTE MEMBRANES CAUSED BY IMMUNE HAEMOLYSIS.免疫性溶血导致的红细胞膜病变
Nature. 1964 Apr 18;202:251-2. doi: 10.1038/202251a0.
2
Effect of antibody and complement on permeability control in ascites tumor cells and erythrocytes.抗体和补体对腹水肿瘤细胞及红细胞通透性调控的影响。
J Exp Med. 1959 Nov 1;110(5):699-713. doi: 10.1084/jem.110.5.699.
3
Phosphorus assay in column chromatography.柱色谱法中的磷测定
膜插入背后的奥秘:补体膜攻击复合物综述
Philos Trans R Soc Lond B Biol Sci. 2017 Aug 5;372(1726). doi: 10.1098/rstb.2016.0221.
4
Complement inhibition by Sarcoptes scabiei protects Streptococcus pyogenes - An in vitro study to unravel the molecular mechanisms behind the poorly understood predilection of S. pyogenes to infect mite-induced skin lesions.疥螨的补体抑制作用可保护化脓性链球菌——一项体外研究,旨在揭示化脓性链球菌易感染螨诱导皮肤损伤这一尚不清楚的偏好背后的分子机制。
PLoS Negl Trop Dis. 2017 Mar 9;11(3):e0005437. doi: 10.1371/journal.pntd.0005437. eCollection 2017 Mar.
5
Complement: an overview for the clinician.补体:临床医生概述
Hematol Oncol Clin North Am. 2015 Jun;29(3):409-27. doi: 10.1016/j.hoc.2015.02.001. Epub 2015 Apr 4.
6
Meningococcal disease and the complement system.脑膜炎球菌病与补体系统。
Virulence. 2014 Jan 1;5(1):98-126. doi: 10.4161/viru.26515. Epub 2013 Oct 8.
7
Crystal structure of C5b-6 suggests structural basis for priming assembly of the membrane attack complex.C5b-6 的晶体结构提示了膜攻击复合物组装的启动的结构基础。
J Biol Chem. 2012 Jun 1;287(23):19642-52. doi: 10.1074/jbc.M112.361121. Epub 2012 Apr 12.
8
T cell activation by terminal complex of complement and immune complexes.T 细胞被补体末端复合物和免疫复合物激活。
J Biol Chem. 2011 Nov 4;286(44):38627-38637. doi: 10.1074/jbc.M111.266809. Epub 2011 Sep 7.
9
Infections of people with complement deficiencies and patients who have undergone splenectomy.补体缺陷患者和脾切除患者的感染。
Clin Microbiol Rev. 2010 Oct;23(4):740-80. doi: 10.1128/CMR.00048-09.
10
Mouse CD4+ CD25+ T regulatory cells are protected from autologous complement mediated injury by Crry and CD59.小鼠CD4+ CD25+ 调节性T细胞受到Crry和CD59的保护,免受自身补体介导的损伤。
Biochem Biophys Res Commun. 2009 Apr 24;382(1):223-6. doi: 10.1016/j.bbrc.2009.03.025. Epub 2009 Mar 10.
J Biol Chem. 1959 Mar;234(3):466-8.
4
Complement-mediated lysis of liposomes produced by the reactive lysis procedure.通过反应性裂解程序产生的补体介导的脂质体裂解。
Immunology. 1970 Dec;19(6):983-6.
5
Immune response of a liposomal model membrane.脂质体模型膜的免疫反应。
Proc Natl Acad Sci U S A. 1968 Sep;61(1):300-7. doi: 10.1073/pnas.61.1.300.
6
Lipid bilayer structure in the membrane of Mycoplasma laidlawii.莱氏无胆甾原体膜中的脂质双层结构。
J Mol Biol. 1971 May 28;58(1):153-65. doi: 10.1016/0022-2836(71)90238-5.
7
The lesions in cell membranes caused by complement.补体引起的细胞膜损伤。
Adv Immunol. 1969;11:75-115. doi: 10.1016/s0065-2776(08)60478-2.
8
Membrane lesions in immune lysis: surface rings, globule aggregates and transient openings.免疫溶解中的膜损伤:表面环、小球聚集体和瞬时开口。
J Cell Biol. 1973 Feb;56(2):528-39. doi: 10.1083/jcb.56.2.528.
9
The membrane attack mechanism of complement. Verification of a stable C5-9 complex in free solution.补体的膜攻击机制。游离溶液中稳定C5-9复合物的验证。
J Exp Med. 1973 Aug 1;138(2):438-51. doi: 10.1084/jem.138.2.438.
10
The ninth component of human complement: isolation, description and mode of action.人类补体的第九个成分:分离、描述及作用方式
Immunology. 1969 Jun;16(6):719-35.